These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 11901002

  • 1. Whole-brain N-acetylaspartate concentration: correlation with T2-weighted lesion volume and expanded disability status scale score in cases of relapsing-remitting multiple sclerosis.
    Bonneville F, Moriarty DM, Li BS, Babb JS, Grossman RI, Gonen O.
    AJNR Am J Neuroradiol; 2002 Mar; 23(3):371-5. PubMed ID: 11901002
    [Abstract] [Full Text] [Related]

  • 2. Relapsing-remitting multiple sclerosis and whole-brain N-acetylaspartate measurement: evidence for different clinical cohorts initial observations.
    Gonen O, Moriarty DM, Li BS, Babb JS, He J, Listerud J, Jacobs D, Markowitz CE, Grossman RI.
    Radiology; 2002 Oct; 225(1):261-8. PubMed ID: 12355014
    [Abstract] [Full Text] [Related]

  • 3. In-vivo evidence for stable neuroaxonal damage in the brain of patients with benign multiple sclerosis.
    Benedetti B, Rovaris M, Rocca MA, Caputo D, Zaffaroni M, Capra R, Bertolotto A, Martinelli V, Comi G, Filippi M.
    Mult Scler; 2009 Jul; 15(7):789-94. PubMed ID: 19465450
    [Abstract] [Full Text] [Related]

  • 4. Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis. Results of a longitudinal magnetic resonance spectroscopy study.
    De Stefano N, Matthews PM, Fu L, Narayanan S, Stanley J, Francis GS, Antel JP, Arnold DL.
    Brain; 1998 Aug; 121 ( Pt 8)():1469-77. PubMed ID: 9712009
    [Abstract] [Full Text] [Related]

  • 5. Axonal loss is progressive and partly dissociated from lesion load in early multiple sclerosis.
    Pascual AM, Martínez-Bisbal MC, Boscá I, Valero C, Coret F, Martínez-Granados B, Marti-Bonmati L, Mir A, Celda B, Casanova B.
    Neurology; 2007 Jul 03; 69(1):63-7. PubMed ID: 17606882
    [Abstract] [Full Text] [Related]

  • 6. Brain atrophy and lesion load predict long term disability in multiple sclerosis.
    Popescu V, Agosta F, Hulst HE, Sluimer IC, Knol DL, Sormani MP, Enzinger C, Ropele S, Alonso J, Sastre-Garriga J, Rovira A, Montalban X, Bodini B, Ciccarelli O, Khaleeli Z, Chard DT, Matthews L, Palace J, Giorgio A, De Stefano N, Eisele P, Gass A, Polman CH, Uitdehaag BM, Messina MJ, Comi G, Filippi M, Barkhof F, Vrenken H, MAGNIMS Study Group.
    J Neurol Neurosurg Psychiatry; 2013 Oct 03; 84(10):1082-91. PubMed ID: 23524331
    [Abstract] [Full Text] [Related]

  • 7. Correlates of MS disability assessed in vivo using aggregates of MR quantities.
    Mainero C, De Stefano N, Iannucci G, Sormani MP, Guidi L, Federico A, Bartolozzi ML, Comi G, Filippi M.
    Neurology; 2001 May 22; 56(10):1331-4. PubMed ID: 11376183
    [Abstract] [Full Text] [Related]

  • 8. Disability and T2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosis.
    Fisniku LK, Brex PA, Altmann DR, Miszkiel KA, Benton CE, Lanyon R, Thompson AJ, Miller DH.
    Brain; 2008 Mar 22; 131(Pt 3):808-17. PubMed ID: 18234696
    [Abstract] [Full Text] [Related]

  • 9. Determinants of disability in multiple sclerosis at various disease stages: a multiparametric magnetic resonance study.
    Pulizzi A, Rovaris M, Judica E, Sormani MP, Martinelli V, Comi G, Filippi M.
    Arch Neurol; 2007 Aug 22; 64(8):1163-8. PubMed ID: 17698707
    [Abstract] [Full Text] [Related]

  • 10. Magnetic resonance spectroscopy of normal appearing white matter in early relapsing-remitting multiple sclerosis: correlations between disability and spectroscopy.
    Ruiz-Peña JL, Piñero P, Sellers G, Argente J, Casado A, Foronda J, Uclés A, Izquierdo G.
    BMC Neurol; 2004 Jun 10; 4():8. PubMed ID: 15191618
    [Abstract] [Full Text] [Related]

  • 11. A longitudinal study of brain atrophy and cognitive disturbances in the early phase of relapsing-remitting multiple sclerosis.
    Zivadinov R, Sepcic J, Nasuelli D, De Masi R, Bragadin LM, Tommasi MA, Zambito-Marsala S, Moretti R, Bratina A, Ukmar M, Pozzi-Mucelli RS, Grop A, Cazzato G, Zorzon M.
    J Neurol Neurosurg Psychiatry; 2001 Jun 10; 70(6):773-80. PubMed ID: 11385012
    [Abstract] [Full Text] [Related]

  • 12. Improved correlation between scores on the expanded disability status scale and cerebral lesion load in relapsing-remitting multiple sclerosis. Results of the application of new imaging methods.
    Riahi F, Zijdenbos A, Narayanan S, Arnold D, Francis G, Antel J, Evans AC.
    Brain; 1998 Jul 10; 121 ( Pt 7)():1305-12. PubMed ID: 9679782
    [Abstract] [Full Text] [Related]

  • 13. Association of nonmyeloablative hematopoietic stem cell transplantation with neurological disability in patients with relapsing-remitting multiple sclerosis.
    Burt RK, Balabanov R, Han X, Sharrack B, Morgan A, Quigley K, Yaung K, Helenowski IB, Jovanovic B, Spahovic D, Arnautovic I, Lee DC, Benefield BC, Futterer S, Oliveira MC, Burman J.
    JAMA; 2015 Jan 20; 313(3):275-84. PubMed ID: 25602998
    [Abstract] [Full Text] [Related]

  • 14. Brain atrophy in relapsing-remitting multiple sclerosis and secondary progressive multiple sclerosis: longitudinal quantitative analysis.
    Ge Y, Grossman RI, Udupa JK, Wei L, Mannon LJ, Polansky M, Kolson DL.
    Radiology; 2000 Mar 20; 214(3):665-70. PubMed ID: 10715027
    [Abstract] [Full Text] [Related]

  • 15. Disability in multiple sclerosis is related to normal appearing brain tissue MTR histogram abnormalities.
    Traboulsee A, Dehmeshki J, Peters KR, Griffin CM, Brex PA, Silver N, Ciccarrelli O, Chard DT, Barker GJ, Thompson AJ, Miller DH.
    Mult Scler; 2003 Dec 20; 9(6):566-73. PubMed ID: 14664468
    [Abstract] [Full Text] [Related]

  • 16. Combined magnetization transfer and proton spectroscopic imaging in the assessment of pathologic brain lesions in multiple sclerosis.
    Pike GB, de Stefano N, Narayanan S, Francis GS, Antel JP, Arnold DL.
    AJNR Am J Neuroradiol; 1999 May 20; 20(5):829-37. PubMed ID: 10369353
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Magnetization transfer ratio histogram analysis of gray matter in relapsing-remitting multiple sclerosis.
    Ge Y, Grossman RI, Udupa JK, Babb JS, Kolson DL, McGowan JC.
    AJNR Am J Neuroradiol; 2001 Mar 20; 22(3):470-5. PubMed ID: 11237968
    [Abstract] [Full Text] [Related]

  • 19. Association of Cortical Lesions With Regional Glutamate, GABA, N-Acetylaspartate, and Myoinositol Levels in Patients With Multiple Sclerosis.
    Madsen MA, Považan M, Wiggermann V, Lundell H, Blinkenberg M, Romme Christensen J, Sellebjerg F, Siebner HR.
    Neurology; 2024 Jul 20; 103(1):e209543. PubMed ID: 38870443
    [Abstract] [Full Text] [Related]

  • 20. Global N-acetylaspartate concentration in benign and non-benign multiple sclerosis patients of long disease duration.
    Achtnichts L, Gonen O, Rigotti DJ, Babb JS, Naegelin Y, Penner IK, Bendfeldt K, Hirsch J, Amann M, Kappos L, Gass A.
    Eur J Radiol; 2013 Dec 20; 82(12):e848-52. PubMed ID: 24041438
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.